PAZOPANIB (PAZOPANIB HYDROCHLORIDE) — all Canadian products
5 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is PAZOPANIB (PAZOPANIB HYDROCHLORIDE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02552957 | AURO-PAZOPANIB | AURO PHARMA INC | Tablet | Oral | PAZOPANIB (PAZOPANIB HYDROCHLORIDE) 200 MG | Marketed | |
| 02525666 | PMS-PAZOPANIB | PHARMASCIENCE INC | Tablet | Oral | PAZOPANIB (PAZOPANIB HYDROCHLORIDE) 200 MG | Marketed | |
| 02352303 | VOTRIENT | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | PAZOPANIB (PAZOPANIB HYDROCHLORIDE) 200 MG | Marketed | |
| 02521180 | SANDOZ PAZOPANIB | SANDOZ CANADA INCORPORATED | Tablet | Oral | PAZOPANIB (PAZOPANIB HYDROCHLORIDE) 200 MG | Cancelled Pre Market | |
| 02352311 | VOTRIENT | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | PAZOPANIB (PAZOPANIB HYDROCHLORIDE) 400 MG | Cancelled Pre Market |
Browse other molecules: